Clinical trial
Soy Supplements in Treating Patients Undergoing Surgery for Localized Prostate…
NCT00345813 · Wake Forest University Health Sciences, Other · Completed
Key facts
| NCT number | NCT00345813 |
|---|---|
| Title | Soy Supplements in Treating Patients Undergoing Surgery for Localized Prostate Cancer |
| Official title | Randomized Phase IIb Preprostatectomy Study of Dietary Supplementation With Soy and Biomarkers of Prostate Cancer Risk and Progression |
| Lead sponsor | Wake Forest University Health Sciences, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Dietary Supplement, Other |
| Interventions | soy isoflavones, soy protein isolate, placebo |
| Enrollment | 62 |
| Start date | Oct 1, 2003 |
| Primary completion | Jul 1, 2006 |
| Completion | Jul 1, 2006 |
| First posted | Jun 29, 2006 |
| Last update posted | Aug 10, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: